Literature DB >> 791112

New medium for in vitro susceptibility studies with amphotericin B.

C J Utz, S White, S Shadomy.   

Abstract

Antibiotic medium 20 FDA and antibiotic medium 3 FDA were compared to determine if antibiotic medium 3 would be suitable for in vitro susceptibility testing with amphotericin B.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 791112      PMCID： PMC429830          DOI： 10.1128/AAC.10.4.776

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing.

Authors:  V Bezjak
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

Review 2.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

3.  Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.

Authors:  G S Hall; C Myles; K J Pratt; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.

Authors:  D L Calhoun; G D Roberts; J N Galgiani; J E Bennett; D S Feingold; J Jorgensen; G S Kobayashi; S Shadomy
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  In vitro studies with ambruticin, a new antifungal antibiotic.

Authors:  S Shadomy; D M Dixon; A Espinel-Ingroff; G E Wagner; H P Yu; H J Shadomy
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

6.  Combined activity of minocycline and amphotericin B in vitro against medically important yeasts.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.